579.74 USD
+0.52
0.09%
At close Dec 20, 4:00 PM EST
After hours
579.74
+0.00
0.00%
1 day
0.09%
5 days
0.58%
1 month
-6.67%
3 months
14.12%
6 months
-3.90%
Year to date
22.46%
1 year
30.00%
5 years
321.20%
10 years
173.98%
 

About: McKesson Corp is one of three leading pharmaceutical wholesalers in the us engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the us pharmaceutical wholesale industry. Outside the us market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

Employees: 51,000

0
Funds holding %
of 6,809 funds
0
Analysts bullish %
of 7 analysts

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

60% more call options, than puts

Call options by funds: $980M | Put options by funds: $613M

4.71% less ownership

Funds ownership: 88.05% [Q2] → 83.34% (-4.71%) [Q3]

6% less funds holding

Funds holding: 1,604 [Q2] → 1,513 (-91) [Q3]

21% less capital invested

Capital invested by funds: $66.6B [Q2] → $53B (-$13.7B) [Q3]

22% less repeat investments, than reductions

Existing positions increased: 505 | Existing positions reduced: 649

27% less funds holding in top 10

Funds holding in top 10: 45 [Q2] → 33 (-12) [Q3]

46% less first-time investments, than exits

New positions opened: 107 | Existing positions closed: 198

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$579
0%
upside
Avg. target
$653
13%
upside
High target
$713
23%
upside

7 analyst ratings

positive
86%
neutral
14%
negative
0%
Morgan Stanley
Erin Wright
48% 1-year accuracy
11 / 23 met price target
11%upside
$642
Overweight
Maintained
17 Dec 2024
Wells Fargo
Stephen Baxter
20% 1-year accuracy
8 / 40 met price target
11%upside
$641
Equal-Weight
Maintained
13 Dec 2024
Citigroup
Daniel Grosslight
41% 1-year accuracy
7 / 17 met price target
23%upside
$713
Buy
Maintained
13 Nov 2024
Evercore ISI Group
Elizabeth Anderson
34% 1-year accuracy
11 / 32 met price target
17%upside
$680
Outperform
Maintained
7 Nov 2024
Baird
Eric Coldwell
32% 1-year accuracy
11 / 34 met price target
19%upside
$688
Outperform
Upgraded
7 Nov 2024

Financial journalist opinion

Based on 24 articles about MCK published over the past 30 days

Positive
Zacks Investment Research
1 day ago
4 Large Cap MedTech Stocks to Keep Winning Streaks Alive in 2025
Investing in large-cap MedTech stocks like MCK, PEN, CAH and PEN can be profitable for investors in 2025.
4 Large Cap MedTech Stocks to Keep Winning Streaks Alive in 2025
Positive
Zacks Investment Research
1 day ago
Best Growth Stocks to Buy for December 20th
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today December 20th:
Best Growth Stocks to Buy for December 20th
Positive
Zacks Investment Research
1 day ago
Buy 5 Value Stocks Amid Strong Upside Potential in the Short Term
Five value stocks have strong revenues and earnings potential in 2025. These are: FAF, MCK, LDOS, SKYW, GAP.
Buy 5 Value Stocks Amid Strong Upside Potential in the Short Term
Neutral
Zacks Investment Research
1 day ago
3 Top Ranked Stocks to Buy for 2025 (GPOR, MCK, MRVL)
Following Wednesday's FOMC meeting and press conference from Jerome Powell, it seems 2025 may be shaping up to be a bit more uncertain than investors were expecting. Powell expressed his concern about rising inflation and signaled the central bank was going to be more hawkish moving forward.
3 Top Ranked Stocks to Buy for 2025 (GPOR, MCK, MRVL)
Positive
Zacks Investment Research
2 days ago
Best Growth Stocks to Buy for December 19th
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today December 19th:
Best Growth Stocks to Buy for December 19th
Positive
Zacks Investment Research
3 days ago
Best Growth Stocks to Buy for December 18th
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today December 18th:
Best Growth Stocks to Buy for December 18th
Positive
Zacks Investment Research
3 days ago
Best Value Stocks to Buy for December 18th
LTM, BBAR and MCK made it to the Zacks Rank #1 (Strong Buy) value stocks list on December 18, 2024.
Best Value Stocks to Buy for December 18th
Positive
Zacks Investment Research
3 days ago
Reasons to Add McKesson Stock to Your Portfolio Right Now
MCK's strategic collaborations and strength in Biologics raise optimism about the stock.
Reasons to Add McKesson Stock to Your Portfolio Right Now
Positive
Zacks Investment Research
4 days ago
Prescription for Profits: 3 Must-Buy Healthcare Stocks Before 2025
The healthcare sector is undergoing significant changes, with technology, innovation and a patient-centric approach as the cornerstones of its growth.
Prescription for Profits: 3 Must-Buy Healthcare Stocks Before 2025
Positive
Zacks Investment Research
5 days ago
Best Growth Stocks to Buy for December 16th
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today December 16th:
Best Growth Stocks to Buy for December 16th
Charts implemented using Lightweight Charts™